QBTS Stock Forecast & Price Target

D-Wave Quantum is supported by a commercially relevant quantum annealing business that is already generating revenue through QCaaS and production deployments, with 2Q QCaaS up 53% year over year to $1.9 million despite being below expectations. Its outlook is strengthened by validation from enterprises such as AT&T, NTT Docomo, Optum Health, and others, while a roughly $600 million cash balance and a fully funded path to profitability reduce financing risk. The company also has differentiated technology, with a dual-rail qubit approach targeting materially better error reduction than competitors and a roadmap toward 17 qubits in 2026, 49 qubits in 2027, and 181 qubits in 2028.

D-Wave Quantum is exposed to a long and uncertain commercialization path because quantum computing remains in the early stages of development, making broad adoption and revenue scaling difficult to predict. Its near-term growth also depends on converting a small set of enterprise and government pilot engagements into recurring QCaaS contracts, while system revenue is recognized over multiple months and at least two quarters, creating lumpy results and execution risk tied to customer readiness. At the same time, heavy competition from IBM, Google, Amazon, and Microsoft, plus setbacks in gate-model development, could limit D-Wave’s ability to diversify beyond annealing-based optimization and sustain profitable growth.